With such extensive and detailed knowledge concerning Hsp70 involvement in cancer progression and drug resistance, gathered throughout decades of extensive research, this protein arises as a major anticancer therapy target whose inhibition would prove beneficial at multiple levels. This evidence concerns the gene HSPA4 and cancer.